Daniel is Chief Operating Officer of Ventus Therapeutics. Previously, Daniel was Chief Business Officer at Arrakis Therapeutics and BIND Therapeutics and held positions at Biogen in Corporate Development, Discovery Research, and Commercial Operations. He founded and served as President of Biogen’s biosimilars business. Daniel is deeply experienced in building high-growth organizations in the US and abroad, designing and implementing creative strategies to build corporate value, financing innovative companies from inception through IPO, negotiating and managing corporate collaborations, and leading groups of diverse functional experts.
He received a B.S. in Biochemistry from Boston College and an MBA from Harvard University.
